99 related articles for article (PubMed ID: 1529547)
1. SV40 small t deletion mutants preferentially transform mononuclear phagocytes and B lymphocytes in vivo.
Cicala C; Pompetti F; Nguyen P; Dixon K; Levine AS; Carbone M
Virology; 1992 Sep; 190(1):475-9. PubMed ID: 1529547
[TBL] [Abstract][Full Text] [Related]
2. Characterization of hamster tumors induced by simian virus 40 small t deletion mutants as true histiocytic lymphomas.
Carbone M; Lewis AM; Matthews BJ; Levine AS; Dixon K
Cancer Res; 1989 Mar; 49(6):1565-71. PubMed ID: 2538229
[TBL] [Abstract][Full Text] [Related]
3. Deletion mutations in the small t antigen gene alter the tissue specificity of tumors induced by simian virus 40.
Matthews BJ; Levine AS; Dixon K
J Virol; 1987 Apr; 61(4):1282-5. PubMed ID: 3029426
[TBL] [Abstract][Full Text] [Related]
4. SV40 induces mesotheliomas in hamsters.
Cicala C; Pompetti F; Carbone M
Am J Pathol; 1993 May; 142(5):1524-33. PubMed ID: 8388174
[TBL] [Abstract][Full Text] [Related]
5. Extended lifespan of normal human B lymphocytes experimentally infected by SV40 or transfected by SV40 large T antigen expression vector.
Alaribe FN; Mazzoni E; Rigolin GM; Rizzotto L; Maniero S; Pancaldi C; Manfrini M; Martini F; Tognon MG
Leuk Res; 2013 Jun; 37(6):681-9. PubMed ID: 23473917
[TBL] [Abstract][Full Text] [Related]
6. Mutations within the hamster polyomavirus large T antigen domain involved in pRb binding impair virus productive cycle and immortalization capacity.
Goutebroze L; de la Roche Saint Andre C; Scherneck S; Feunteun J
Oncogene; 1993 Mar; 8(3):685-93. PubMed ID: 8382359
[TBL] [Abstract][Full Text] [Related]
7. Can SV40 infect and immortalize human B-lymphocytes and mesothelial cells as a natural pathogen?
Jasani B; Butel JS
Leuk Res; 2013 Jun; 37(6):607-8. PubMed ID: 23601746
[No Abstract] [Full Text] [Related]
8. The biological activities of simian virus 40 large-T antigen and its possible oncogenic effects in humans.
Matker CM; Rizzo P; Pass HI; Di Resta I; Powers A; Mutti L; Kast WM; Carbone M
Monaldi Arch Chest Dis; 1998 Apr; 53(2):193-7. PubMed ID: 9689808
[TBL] [Abstract][Full Text] [Related]
9. Simian virus 40 tumor antigen expression and immunophenotypic profile of AIDS-related non-Hodgkin's lymphoma.
Vilchez RA; Lopez-Terrada D; Middleton JR; Finch CJ; Killen DE; Zanwar P; Jorgensen JL; Butel JS
Virology; 2005 Nov; 342(1):38-46. PubMed ID: 16122775
[TBL] [Abstract][Full Text] [Related]
10. Simian virus 40 sequences in malignant lymphomas in Japan.
Nakatsuka S; Liu A; Dong Z; Nomura S; Takakuwa T; Miyazato H; Aozasa K;
Cancer Res; 2003 Nov; 63(22):7606-8. PubMed ID: 14633675
[TBL] [Abstract][Full Text] [Related]
11. Loss or persistence of the differentiated state of simian virus 40-induced hamster tumor cells before and after serial passage in culture.
Diamandopoulos GT; Miller MH; McLane MF; Evans PG
Cancer Res; 1976 Sep; 36(9 pt.1):3171-7. PubMed ID: 184942
[TBL] [Abstract][Full Text] [Related]
12. Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice.
Hoser D; Schön C; Loddenkemper C; Lohneis P; Kühl AA; Sommermann T; Blankenstein T; Willimsky G
Blood; 2018 Aug; 132(9):924-934. PubMed ID: 30002144
[TBL] [Abstract][Full Text] [Related]
13. The SV40 small t antigen is essential for the morphological transformation of human fibroblasts.
de Ronde A; Sol CJ; van Strien A; ter Schegget J; van der Noordaa J
Virology; 1989 Jul; 171(1):260-3. PubMed ID: 2662578
[TBL] [Abstract][Full Text] [Related]
14. Oncogenicity in newborn and adult Syrian hamsters of SV40 temperature-sensitive (ts) mutants.
Deichman G; Kashkina L; Rapp F
Neoplasma; 1979; 26(1):49-56. PubMed ID: 219381
[TBL] [Abstract][Full Text] [Related]
15. Simian virus 40 oncogenesis in hamsters.
Carbone M; Stach R; Di Resta I; Pass HI; Rizzo P
Dev Biol Stand; 1998; 94():273-9. PubMed ID: 9776247
[TBL] [Abstract][Full Text] [Related]
16. Converting the JCV T antigen Rb binding domain to that of SV40 does not alter JCV's limited transforming activity but does eliminate viral viability.
Tavis JE; Trowbridge PW; Frisque RJ
Virology; 1994 Mar; 199(2):384-92. PubMed ID: 8122368
[TBL] [Abstract][Full Text] [Related]
17. In vivo induction of tumor-specific immunity by glycolipid extracts of SV40-transformed cells.
Ansel S; Blangy D
Int J Cancer; 1984 Oct; 34(4):555-9. PubMed ID: 6092285
[TBL] [Abstract][Full Text] [Related]
18. Immortalization of human cells by mutant and chimeric primate polyomavirus T-antigen genes.
O'Neill FJ; Frisque RJ; Xu X; Hu YX; Carney H
Oncogene; 1995 Mar; 10(6):1131-9. PubMed ID: 7700639
[TBL] [Abstract][Full Text] [Related]
19. An amino-terminal fragment of SV40 T antigen transforms REF52 cells.
Sompayrac L; Danna KJ
Virology; 1992 Nov; 191(1):439-42. PubMed ID: 1329329
[TBL] [Abstract][Full Text] [Related]
20. The cellular chromatin is an important target for SV40 large T antigen in maintaining the transformed phenotype.
Richter W; Deppert W
Virology; 1990 Feb; 174(2):543-56. PubMed ID: 2154889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
